Compare
5 stocks, side by sideRelative performance · rebased to 100
INVAAKTSABSIBCAXANAB
| INVAInnoviva, Inc. | AKTSAktis Oncology, Inc. | ABSIAbsci Corporation | BCAXBicara Therapeutics Inc. | ANABAnaptysBio, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 10/10 | 9/10 | 8/10 | 10/10 | 6/10 |
| Price | $23.35 | $31.15 | $10.21 | $26.34 | $59.68 |
| 1 month | +3.0% | +51% | +93% | +20% | +3.3% |
| 1 year | +13% | - | +263% | +177% | +284% |
| 5 year | +80% | - | - | - | +259% |
| P/E (TTM) | 3.4 | -27.5 | -14.6 | -11.0 | -64.8 |
| P/E vs sector | -89% | - | - | - | - |
| Market cap | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.